An observational study in Cleft Lip, Congenital Nose Malformation and Deformity, sponsored by Johns Hopkins University. Withdrawn at 1 site in United States. Open to participants aged 0 Months to 1 Month. Per ClinicalTrials.gov, last updated 2023-08-21.
Sponsored by Johns Hopkins University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Cleft Lip with a site in United States — 11 open to participants now, 12 under way, 1 of them phase 3. Cleft Lip · United States.
Among the 28 studies in Cleft Lip with a site in United States, this one is the 12th largest by enrollment of the 12 observational ones that give a count, is one of 3 that started in 2020, is one of 12 observational ones, and was the 16th registered.
168 studies on the registry are indexed under Cleft Lip; 51 are open to participants now.
Browse Cleft Lip studies →11 of the 28 studies in Cleft Lip with a site in United States are open now. Recruiting first, the newest first:
Children's National Research Institute · Sites in United States
Ages 0 days–12 mo
Ohio State University · Sites in United States
Wake Forest University Health Sciences · Sites in United States
Ages 2–99
Kerry O'Rourke · Sites in United States
Ages 6+
Children's Hospital Los Angeles · Sites in United States
Ages 6–20 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 28 Cleft Lip studies recruiting now, 8 (29%) set no upper age limit and 19 (68%) stop at 75 or younger; 26 take children under 18; 8 take healthy volunteers.
This study: 0 Months to 1 Month · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 4 · Phase 3 2 · Phase 4 2
First in 1996; this study’s year is marked. 3 started in 2020.
By drug class, each counting the studies that test any of its medicines:
Median enrollment 54 across the 16 interventional studies, 122 across the 12 observational. Of the 15 that completed or were terminated, 2 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 28 has an industry lead sponsor. The 10 most frequent:
Johns Hopkins University is the lead sponsor of 1,817 studies on the registry; 316 are open to participants now.
Of its 208 completed or terminated interventional studies of FDA-regulated products, 144 (69%) have results posted.
Johns Hopkins University has 1 study filed under Cleft Lip — fewer than ten, so there is no comparison to draw.
5 of the studies in Cleft Lip with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06122805Children's Hospital Los AngelesEffectiveness of Dual Light Electric Toothbrush vs. Manual Toothbrush in Orthodontic Patients Undergoing Oral Surgery | 2026-11-30 |
| NCT06801535Wake Forest University Health SciencesEfficacy of 3D-Printed Mouth Splints | 2026-12 |
| NCT07219901Old Dominion UniversityEarly Intervention in Infants With Unrepaired Cleft Palate: Language, Palatal Function, and Articulation. | 2026-12-31 |
| NCT07880860Children's National Research InstituteCleft Lip Scarring After Botox | 2027-02 |
| NCT04771156The University of Texas Health Science Center, HoustonKetorolac in Palatoplasty | 2027-03-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 28 studies in Cleft Lip with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
There is a robust body of research suggesting that the use of pre-surgical orthopedic devices prior to definitive cleft lip/nose repair results in significant improvement of facial aesthetics with long term follow up. However, in recent surveys of the cleft centers in the US, only 30% of cleft centers offer PSIOs, and only 13% routinely report its use. Accordingly, thirty percent of centers utilize a two-stage cleft lip/nose repair in the centers' algorithm (1st: lip adhesion; 2nd: final lip repair). The major drawback to a two-stage cleft procedure is the administration of two general anesthetics to an infant before the age of one year. There is a growing amount of evidence that multiple anesthetic experiences before a certain age could affect brain development.
It is difficult to make inferences as to why clinicians are not utilizing surgical aids to decrease the size of the cleft width, but even when PSIO is offered, caregivers experience additional, potentially prohibitive challenges. In one study, caregivers traveled an average of 70 miles to visit the nearest cleft center offering pre-surgical orthopedic devices. As these devices are created by hand every 1-2 weeks after seeing the child in clinic, parents are required to travel to clinic multiple times per month. Not surprisingly, infants who were first-born and those who did not have other siblings were more likely to receive pre-surgical orthopedic treatment than infants who were residing with other siblings.
Given the benefits of PSIOs and the barriers both to healthcare systems and patients' families associated with PSIOs in its current form, a new form of pre-surgical clinical management is needed.
Objectives:
Approximately 7000 babies are born with a cleft lip and/or cleft palate in the United States per year. Globally, this defect is staggeringly common, with 100,000 new cases per year. This defect is due to a failure of normal fusion between facial structures, causing a full thickness gap of the upper lip involving skin, muscle, and other connective tissue. Due to aberrant insertion of the muscle underlying the lip as well as abnormal formation of deeper facial structures, the nose is also displaced inferiorly, laterally, and posteriorly. The wider the cleft, the more challenging the repair.
Current best practice in treating unilateral cleft lip and nose deformity involves presurgical infant orthopedics (PSIOs). PSIOs involves presurgically treating the deformity using custom orthodontics to gradually bring the two halves of the cleft together, reducing defect size and enabling complete repair with one surgery during early infancy. However, creation of these molds is time consuming and requires the expertise of a cleft orthodontist and weekly visits to the hospital for device advancement. As not all cleft centers have a specialized cleft orthodontist-including Johns Hopkins Hospital-many are unable to provide presurgical infant orthopedics. Weekly travel to cleft centers can also pose a significant temporal and financial burden to families, as the average patient is located over 60 miles from the nearest cleft center. In a recent survey of cleft centers in the United States, only 30% of these centers are able to provide presurgical orthopedic molding devices in treatment protocols. These centers therefore correct wide clefts with a staged, two-surgery approach. This approach is often less successful in both adequately aligning the gum and in repairing nasal defects, and usually requires intensive orthodontics and additional surgeries in adolescence. As the defect is not fully corrected in infancy, children are additionally subjected to the emotional and psychological difficulty and damage to self-esteem associated with the persistent defect.
With the advent of 3D printing technology, the investigators are now in the planning stages of implementing a new clinical protocol to bring PSIOs to Johns Hopkins Hospital (JHH). A cleft orthodontist at an equipped center will remotely design these orthodontic molds, which will then be 3D printed using dental acrylic (the same material currently used in hand-fabricated orthodontic models) and given to patients in the investigators' clinic. As planning these devices for 3D printing can be done remotely in a fraction of the time it would take to create each one by hand, this change in clinical practice will eliminate the need for an in-person specialized craniofacial orthodontist on faculty where one does not exist.
This research study seeks to elucidate both the investigators' current standard of cleft practice and the benefits the investigators hope to see after implementing this change in clinical practice. The investigators expect that although the investigators will initially create each new mold after a weekly hospital visit with in-person measurements, the investigators ultimately aim to develop an algorithm to predict early growth and development of the newborn's facial skeleton and soft tissue. This will allow the fabrication of sequential pre-surgical orthopedic molding devices based of the infant's predicted facial growth, which can be delivered en bloc to the infants home, thereby eliminating the need for frequent visits to geographically inconvenient centers. After 4-5 months of using these devices, the bony cleft gap will be closed, the nose straightened, and the child be ready for the definitive cleft lip and nose repair in a single surgery. These devices will not only physically close the gap of the cleft lip deformity, but will also close the gap in access to the necessary specialists for the ideal management of cleft deformities across the country. With this technology, any cleft center can offer naso-alveolar molding to every child born with cleft lip and palate in the country.
Newborns either born in Johns Hopkins or presenting to clinic with a cleft lip between 0-1 months of life.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants who will undergo cleft lip/nose repair prior to addition of PSIO as part of standard of care in Hopkins.
Procedure: Cleft Lip/Nose Repair without PSIO
Participants who will undergo cleft lip/nose repair after addition of PSIO as part of standard of care in Hopkins.
Procedure: Presurgical Infant Orthopedic Therapy
Standard of care surgical repair of cleft lip/nose without PSIO.
Standard of care surgical repair of cleft lip/nose with PSIO.
Percentage of cleft patients with an alveolar cleft of <5 mm at time of the first surgery
Percentage of cleft patients with an alveolar cleft of \<5 mm at time of the first surgery will be assessed to determine the effect of 3D printed orthognathic pre-surgical molding devices on cleft care.
Time frame: At the time of first surgery (3 months)
Cleft size at initial clinic presentation
Cleft size in millimeters (mm) at initial clinic presentation.
Time frame: At the time of initial clinic visit up to 1 hour
Size of cleft at pre- and post-operative clinic visit
Size of cleft in millimeters at pre- and post-operative clinic visit
Time frame: At pre- and post-operative clinic visit, up to 4 months
Rate of change in cleft size
The rate of change in cleft size (mm/week).
Time frame: Weekly, up 8 weeks
Length of time to achieve a cleft <5 mm
Length of time in days to achieve a cleft \<5 mm.
Time frame: Up to 4 months
Aesthetic outcome following cleft surgical repair as assessed by the surgeon
Aesthetic outcome following cleft surgical repair wiil be assessed by the surgeon using a clinical judgment.
Time frame: Post surgery, up to 4 months
Satisfaction with the 3-D printed pre-surgical orthopedic device as assessed by parents
Satisfaction with the 3-D printed pre-surgical orthopedic device will be assessed by a satisfaction questionnaire administered to parents.
Time frame: Post surgery, up to 4 months
Started Jun 2020 (actual). Primary completion is estimated for Apr 2022, 22 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.